The Biden administration is reportedly weighing the appointment of Kyle Diamantas, currently the FDA’s Deputy Commissioner overseeing food operations, to serve as interim leader of the federal agency, according to three individuals with knowledge of the deliberations.
This potential move comes as the White House has already approved plans to dismiss current FDA Commissioner Marty Makary, as Reuters reported earlier Friday. The Wall Street Journal was first to break this development.
Sources indicate that several candidates are under consideration for the permanent position leading the agency. Among those being evaluated are Stephen Hahn, who previously served as FDA commissioner, and Brett Giroir, who held roles as both acting commissioner and assistant Health Secretary.
The leadership shake-up at the Food and Drug Administration represents a significant change for the federal agency responsible for regulating food safety, pharmaceuticals, and medical devices across the United States.
